Identifying novel glioma associated pathways based on integrated 'omics' data

2012 IEEE 6th International Conference on Systems Biology, ISB 2012

Volumn , Issue , 2012, Pages 49-55

  Hu, Yangfan ^a   Li, Jinquan ^a   Chen, Jiajia ^a,b   Hu, Guang ^a   Shen, Bairong ^a  

^a SOOCHOW UNIVERSITY   (China)

^b SUZHOU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

glioma; meta analysis; omics data; pathway enrichment analysis

Indexed keywords

DATA SETS; DIFFERENTIALLY EXPRESSED GENE; EXPERIMENTAL VERIFICATION; EXPRESSION PROFILE; GENE LEVELS; GLIOMA; HIGH THROUGHPUT TECHNOLOGY; META-ANALYSIS; MICROARRAY DATA SETS; MICRORNA EXPRESSION; OMICS DATA; PATHWAY ENRICHMENT ANALYSIS; SYSTEM LEVELS;

DATA REDUCTION; GENE EXPRESSION;

TUMORS;

EID: 84868670234     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/ISB.2012.6314112     Document Type: Conference Paper

References (41)

1. L. Ein-Dor, I. Kela, G. Getz, D. Givol, and E. Domany, "Outcome signature genes in breast cancer: is there a unique set?" Bioinformatics, vol. 21, (no. 2), pp. 171-8, Jan 2005.
2. L. Tian, S. A. Greenberg, S. W. Kong, J. Altschuler, I. S. Kohane, and P. J. Park, "Discovering statistically significant pathways in expression profiling studies," Proc Natl Acad Sci U S A, vol. 102, (no.38), pp. 13544-9, Sep 2005.
3. K. Shen, and G.C. Tseng, "Meta-analysis for pathway enrichment analysis when combining multiple genomic studies," Bioinformatics, vol. 26, (no.10), pp. 1316-23, Apr 2010.
4. O. Martinho, S. Granja, T. Jaraquemada, C. Caeiro, V. Miranda-Goncalves, M. Honavar, et al., "Downregulation of RKIP is associated with poor outcome and malignant progression in gliomas," PLoS One, vol. 7, (no. 1), e30769, Jan 2012
5. H. Ohgaki, P. Dessen, B. Jourde, S. Horstmann, T. Nishikawa, P. L. Di Patre, et al., "Genetic pathways to glioblastoma: a population-based study," Cancer Res, vol. 64. (no. 19), pp. 6892-9, Oct 2004.
6. D. Faratian, A. Goltsov, G. Lebedeva, A. Sorokin, S. Moodie, P. Mullen, et al., "Systems biology reveals new strategies for personalizing cancer medicine and confirms the role of PTEN in resistance to trastuzumab," Cancer Res, vol. 69, (no. 16), pp. 6713-20, Aug 2009.
7. I.G. Khalil, and C. Hill, "Systems biology for cancer," Curr Opin Oncol, vol. 17, (no. 1), pp. 44-8, Jan 2005.
8. T. Manoli, N. Gretz, H. J. Grone, M. Kenzelmann, R. Eils, and B. Brors, "Group testing for pathway analysis improves comparability of different microarray datasets," Bioinformatics, vol. 22, (no. 20), pp. 2500-6, Oct 2006.
9. Y. Wang, J. J. Chen, Q. H. Li, H. Y. Wang, G. Q. Liu, Q. Jing, et al., "Identifying novel prostate cancer associated pathways based on integrative microarray data analysis," Comput Biol Chem, vol. 35, (no. 3), pp. 151-8, Jun 2011.
10. J.W. MacDonald, and D. Ghosh, "COPA - cancer outlier profile analysis," Bioinformatics, vol. 22, (no. 23), pp. 2950-1, Dec 2006.
11. A. Subramanian, P. Tamayo, V. K. Mootha, S. Mukherjee, B. L. Ebert, M. A. Gillette, et al., "Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles," Proc Natl Acad Sci U S A, vol. 102, (no.43), pp.15545-50, Oct 2005.
12. S. M. Pollard, K. Yoshikawa, I. D. Clarke, D. Danovi, S. Stricker, R. Russell, et al., "Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens," Cell Stem Cell, vol. 4, (no. 6), pp. 568-80, Jun 2009.
13. L. A. M. Gravendeel, M. C. M. Kouwenhoven, O. Gevaert, J. J. de Rooi, A. P. Stubbs, J. E. Duijm, et al., "Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology," Cancer Res, vol. 69, (no. 23), pp. 9065-72, Dec 2009.
14. Y. Kotliarov, S. Kotliarova, N. Charong, A. G. Li, J. Walling, E. Aquilanti, et al., "Correlation analysis between single-nucleotide polymorphism and expression arrays in gliomas identifies potentially relevant target genes," Cancer Res, vol. 69, (no. 4), pp. 1596-603, Feb 2009.
15. D. R. Rhodes, J. J. Yu, K. Shanker, N. Deshpande, R. Varambally, D. Ghosh, et al., "Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression," Proc Natl Acad Sci U S A, vol. 101, (no. 25), pp. 9309-14, Jun 2004.
16. N. J. Chung, X. D. Zhang, A. Kreamer, L. Locco, P. F. Kuan, S. Bartz, et al., "Median absolute deviation to improve hit selection for genome-scale RNAi screens," J Biomol Screen, vol. 13, (no. 2), pp. 149-58, Feb 2008.
17. K. A. Baggerly, K. R. Coombes, K. R. Hess, D. N. Stivers, L. V. Abruzzo, and W. Zhang, "Identifying differentially expressed genes in cDNA microarray experiments," J Comput Biol, vol. 8, (no. 6), pp. 639-59, 2001.
18. B. Wu, "Cancer outlier differential gene expression detection," Biostatistics, vol. 8, (no. 3), pp. 566-75, Jul 2007.
19. H. Lian, "MOST: detecting cancer differential gene expression," Biostatistics, vol. 9, (no. 3), pp. 411-8, Jul 2008.
20. R. I. Gregory, and R. Shiekhattar, "MicroRNA biogenesis and cancer," Cancer Res, vol. 65, (no. 9), pp.3509-3512, May 2005.
21. G. A. Calin, and C. M. Croce, "MicroRNA signatures in human cancers," Nat Rev Cancer. vol. 6, (no.11), pp.857-866, Nov 2006.
22. A. Esquela-Kerscher, and F. J. Slack, "Oncomirs - microRNAs with a role in cancer," Nat Rev Cancer. vol. 6, (no. 4), pp.259-269, Apr 2006.
23. Y. Ren, X. Zhou, M. Mei, X. B. Yuan, L. Han, G. X. Wang, et al., "MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol," BMC Cancer, vol. 10, pp. 27, Jan 2010.
24. B. John, A. J. Enright, A. Aravin, T. Tuschl, C. Sander, and D. S. Marks, "Human MicroRNA targets," PLoS Biol, vol. 2, (no. 11), 1862-1879, Nov 2004.
25. M. Rehmsmeier, P. Steffen, M. Hochsmann, and R. Giegerich, "Fast and effective prediction of microRNA/target duplexes," RNA, vol. 10, (no. 10), pp. 1507-17, Oct 2004.
26. M. Sturm, M. Hackenberg, D. Langenberger, and D. Frishman, "TargetSpy: a supervised machine learning approach for microRNA target prediction," BMC Bioinformatics, vol. 11, pp. 292, May 2010.
27. A. Diaz, K. Park, D. A. Lim, and J. S. Song, "Normalization, bias correction, and peak calling for ChIP-seq," Stat Appl Genet Mol Biol, vol. 11, (no. 3), Mar 2012.
28. D. S. Johnson, A. Mortazavi, R. M. Myers, and B. Wold, "Genomewide mapping of in vivo protein-DNA interactions," Science, 316, pp.1497-1502, Jun 2007.
29. X. F. Fang, J. G. Yoon, L. S. Li, W. Yu, J. F. Shao, D. S. Hua, et al., "The SOX2 response program in glioblastoma multiforme: an integrated ChIP-seq, expression microarray, and microRNA analysis," BMC Genomics, vol. 12, pp. 11, Jan 2011.
30. Y. Zhang, T. Liu, C. A. Meyer, J. Eeckhoute, D. S. Johnson, B. E. Bernstein, et al., "Model-based analysis of ChIP-Seq (MACS)," Genome Biol, vol. 9, (no. 9), pp. R137, 2008.
31. R. Jothi, S. Cuddapah, A. Barski, K. Cui, K. Zhao, "Genome-wide identification of in vivo protein-DNA binding sites from ChIP-Seq data," Nucleic Acids Res, vol. 36, (no. 16), pp. 5221-31, 2008.
32. P. Katara, S. Neeru, S. Sugandha, K. Indu, K. Akansha, K. Lalima, and S. Vinay, "Comparative microarray data analysis for the expression of genes in the pathway of glioma," Bioinformation, vol. 5, (no. 1), pp. 31-4, Jun 2010.
33. A. S. Abdoon, N. Ghanem, O. M. Kandil, A. Gad, K. Schellander, and D. Tesfaye, "cDNA microarray analysis of gene expression in parthenotes and in vitro produced buffalo embryos," Theriogenology, vol. 77, (no. 6), pp. 1240-51, Apr 2012.
34. L. A. M. Gravendeel, M. C. M. Kouwenhoven, O. Gevaert, J. J. de Rooi, A. P. Stubbs, J. E. Duijm, et al., "Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology," Cancer Res, vol. 69, (no. 23), pp. 9065-72, Dec 2009.
35. J. M. Dreyfuss, M. D. Johnson, and P. J. Park, "Meta-analysis of glioblastoma multiforme versus anaplastic astrocytoma identifies robust gene markers," Mol Cancer, vol. 8, pp. 71, Sep 2009.
36. M. Xia, M. H. Hu, J. Wang, Y. J. Xu, X. B. Chen, Y. D. Ma, et al., "Identification of the role of Smad interacting protein 1 (SIP1) in glioma," J Neurooncol, vol. 97, (no. 2), pp. 225-32, Apr 2010.
37. S. Penuelas, J. Anido, R. M. Prieto-Sanchez, G. Folch, I. Barba, I. Cuartas, et al., "TGF-beta increases glioma-initiating cell self- renewal through the induction of LIF in human glioblastoma," Cancer Cell, vol. 15, (no. 4), pp. 315-27, Apr 2009.
38. T. D. Gilmore, M. Koedood, K. A. Piffat, and D. W. White, "Rel/NFkappaB/ IkappaB proteins and cancer," Oncogene, vol. 13, (no. 7), pp. 1367-78, Oct 1996.
39. C. H. Lee, Y. T. Jeon, S. H. Kim, and Y. S. Song, "NF-kappaB as a potential molecular target for cancer therapy," Biofactors, vol. 29, (no. 1), pp. 19-35, 2007.
40. F. Lerebours, S. Vacher, C. Andrieu, M. Espie, M. Marty, R. Lidereau, et al., "NF-kappa B genes have a major role in inflammatory breast cancer," BMC Cancer, vol. 8, pp. 41, Feb 2008.
41. W. Li, X. R. Liu, B. Zhang, D. X. Qi, L. H. Zhang, Y. H. Jin, et al., "Overexpression of candidate tumor suppressor ECRG4 inhibits glioma proliferation and invasion," J Exp Clin Cancer Res, vol. 29, pp. 89, Jul 2010.